Cargando…
UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations
Cannabidiol (CBD) is a promising therapeutic agent with analgesic, myorelaxant, and anti-epileptic actions. Recently, a purified form of CBD (Epidiolex(®)) has been approved by the European Medicines Agency (EMA) for the treatment of two highly-refractory childhood-onset epilepsies (Dravet and Lenno...
Autores principales: | Malaca, Sara, Gottardi, Massimo, Pigliasco, Federica, Barco, Sebastiano, Cafaro, Alessia, Amadori, Elisabetta, Riva, Antonella, Marcenaro, Martina, Striano, Pasquale, Cangemi, Giuliana, Pacifici, Roberta, Pichini, Simona, Busardò, Francesco Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308640/ https://www.ncbi.nlm.nih.gov/pubmed/34209666 http://dx.doi.org/10.3390/ph14070630 |
Ejemplares similares
-
Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients
por: Pigliasco, Federica, et al.
Publicado: (2022) -
A UHPLC–MS/MS Method for Therapeutic Drug Monitoring of Aciclovir and Ganciclovir in Plasma and Dried Plasma Spots
por: Pigliasco, Federica, et al.
Publicado: (2021) -
Development and Validation of a Novel LC-MS/MS Method for a TDM-Guided Personalization of HSCT Conditioning with High-Dose Busulfan in Children
por: Cafaro, Alessia, et al.
Publicado: (2023) -
A Novel LC–MS/MS-Based Method for the Diagnosis of ADA2 Deficiency from Dried Plasma Spot
por: Cafaro, Alessia, et al.
Publicado: (2021) -
A Volumetric Absorptive Microsampling Technique to Monitor Cannabidiol Levels in Epilepsy Patients
por: Dubois, Sara, et al.
Publicado: (2020)